PT-141 (Bremelanotide) Consent Template
$599
PT-141 (Bremelanotide) is a prescription peptide therapy used to support sexual health and function in both men and women. Unlike traditional treatments, PT-141 works centrally through melanocortin receptors in the brain to enhance sexual desire and arousal, rather than acting on the vascular system.
Before beginning treatment, all patients complete a comprehensive informed consent process covering how PT-141 works, its potential benefits, known side effects, contraindications, and patient responsibilities. As PT-141 use in certain contexts may be considered investigational, our consent process ensures full transparency and informed decision-making under qualified medical supervision.
